MobileSmith Announces Christine Havlin as Their Chief Marketing Officer

RALEIGH, N.C.–(BUSINESS WIRE)–MobileSmith (OTCBB: MOST), a leading provider of cutting-edge mobile software solutions, announces the appointment of Christine Havlin as their Chief Marketing Officer. “As MSH adds more clinical functionality to our platform it became a strategic imperative to add a marketing leader with deep provider experience. We are thrilled to add Christine to lead … [Read more…]

Global Healthcare Asset Management Market (2022 to 2027) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Healthcare Asset Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global healthcare asset management market reached a value of US$ 13.35 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 25.93 Billion by 2027, exhibiting at a … [Read more…]

Tia Extends “Whole Woman, Whole Life” Care Model With Fertility Services

The new service line seeks to connect fertility to comprehensive women’s healthcare with unbiased counseling, prevention-focused care, and mental health support The women’s healthcare start-up also released its first brand campaign called “Trying” questioning the social pressure put on women in their fertility journeys & choices NEW YORK–(BUSINESS WIRE)–Tia, the modern medical home for women, … [Read more…]

TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA®

– ANNOVERA is the only FDA-approved procedure-free, long-lasting, reversible birth control – – With this approval, the Company expects a significant reduction in its manufacturing batch rejections and an increase in future product supply and will enable the Company to better meet short- and long-term customer demand – BOCA RATON, Fla.–(BUSINESS WIRE)–TherapeuticsMD, Inc. (NASDAQ:TXMD) (“TXMD” … [Read more…]

Shore Capital Partners Announces Partnership with AA Medical

CHICAGO–(BUSINESS WIRE)–Shore Capital Partners (“Shore” or “Shore Capital”) is pleased to announce it has completed a partnership with AA Medical, a provider of sustainable solutions to both the new and resale medical device equipment markets based in Mokena, Illinois, with a second location in Miami, Florida. AA Medical was founded in 2012 by Ron Plantz … [Read more…]

Tentarix Biotherapeutics Announces the Strengthening of its Leadership and Advisory Teams

SAN DIEGO & VANCOUVER, British Columbia–(BUSINESS WIRE)–Tentarix Biotherapeutics LP, a biotechnology company developing first-in-class targeted, conditional antibody-based multifunctional biotherapies, today announced the formation of a Scientific Advisory Board (SAB) and appointments to its Board of Directors and leadership team. The SAB, initially comprised of three experts in immunology, cancer biology and protein engineering, will provide … [Read more…]

Tenaya Therapeutics to Present Preclinical Data on TN-301 HDAC6 Inhibitor at European Society of Cardiology Heart Failure 2022 Conference

Heart Failure 2022 Presentation Includes Preclinical Data Supporting TN-301 Effect in HFpEF Models TN-301 IND Submission on Track for Second Half of 2022 SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced that … [Read more…]

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Adolescent (≥12 Years of Age) Patients With Stage IIB or IIC Melanoma Following Complete Resection

Opinion granted based on positive results from the Phase 3 KEYNOTE-716 trial If approved, KEYTRUDA would be the first anti-PD-1 immunotherapy treatment option for patients 12 years and older in the EU across stage IIB, IIC and III melanoma following complete resection RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States … [Read more…]

Cortexyme Appoints Dr. Philip Low to Its Board of Directors

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company pioneering therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, today announced the appointment of Dr. Philip S. Low, a renowned targeted drug discovery researcher and veteran biotech entrepreneur, to the company’s Board of Directors. “In conjunction with today’s acquisition … [Read more…]

Merz Aesthetics Partners With North Carolina Courage of the National Women’s Soccer League to Fuel Confidence on and off the field

Merz Aesthetics logo will be featured on lower back of NC Courage home and away jerseys through 2023 Sponsor of community programs to encourage confidence, character and sportsmanship among local teenage girls RALEIGH, N.C.–(BUSINESS WIRE)–Merz Aesthetics, the world’s largest dedicated medical aesthetics business, is pleased to kick off a new partnership with the North Carolina … [Read more…]